OTC

Strength

1; 2.5 mg/5mL; mg/5mL

NDC

00485020216

Classification

Generic

Dosage Form

LIQUID

Route

ORAL

Last Updated

4/22/2026

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

3/7/2011

Pharmacological Classes

Adrenergic alpha1-Agonists
alpha-1 Adrenergic Agonist

Price History

1W

0.0%

1M

-0.1%

3M

+7.4%

6M

+7.4%

1Y

+7.4%

3Y

+38.5%

5Y

+38.5%

All

+45.0%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.